SCHEMBL1632243

SCHEMBL1632243

NS(=O)(=O)c1ccc(Nc2ncc3ccc(-c4cccnc4)c(OC4CCNCC4)c3n2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IKBKB O14920 9/20 0.47
CHUK O15111 4/20 0.47
AKT1 P31749 1/20 0.47
ROCK1 Q13464 1/20 0.47
MEN1 O00255 1/20 0.43
NPC1 O15118 1/20 0.43
KMT2A Q03164 1/20 0.43
NCOA3 Q9Y6Q9 1/20 0.43
JAK2 O60674 1/20 0.42
JAK1 P23458 1/20 0.42
TYK2 P29597 1/20 0.42
JAK3 P52333 1/20 0.42
CA2 P00918 3/20 0.41
CA1 P00915 2/20 0.41
CA9 Q16790 2/20 0.41
CA4 P22748 1/20 0.41
CA12 O43570 1/20 0.41
MKNK1 Q9BUB5 1/20 0.41
MKNK2 Q9HBH9 1/20 0.41
CCNT1 O60563 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1632574 0.92 CA1 (0.47) IKBKBCHUKAKT1ROCK1JAK2
SCHEMBL1632401 0.91 IKBKB (0.52) IKBKBCHUKAKT1ROCK1JAK2
SCHEMBL1631355 0.88 IKBKB (0.45) IKBKBCHUKAKT1ROCK1JAK2
SCHEMBL1633309 0.88 IKBKB (0.44) IKBKBCHUKAKT1ROCK1JAK2
SCHEMBL1634447 0.88 IKBKB (0.49) IKBKBCHUKAKT1ROCK1JAK2
SCHEMBL1632495 0.87 IKBKB (0.45) IKBKBCHUKAKT1ROCK1JAK2
SCHEMBL1632587 0.87 IKBKB (0.43) IKBKBCHUKAKT1ROCK1JAK2
SCHEMBL1634265 0.87 IKBKB (0.45) IKBKBCHUKAKT1ROCK1JAK2
SCHEMBL1632714 0.86 CA1 (0.43) IKBKBCHUKAKT1ROCK1JAK2
SCHEMBL1633008 0.86 CDK1 (0.46) IKBKBCHUKAKT1ROCK1JAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 US disclosed
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 US disclosed
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 US disclosed